Abbar et al. conducted a double-blind, randomised, placebo-controlled trial published in the BMJ in 2022, which investigated the use of ketamine for the acute treatment of severe suicidal ideation.

Authors

• Person: Not available Organization: Frontiers in Psychiatry
  The Montreal model: an integrative biomedical-psychedelic ...

Sources

• The Montreal model: an integrative biomedical-psychedelic ... www.frontiersin.org Frontiers in Psychiatry via serper

Referenced by nodes (2)

• ketamine concept
• suicidal ideation concept